What Is GHRP-6 Peptide?
GHRP-6 is a synthetic hexapeptide consisting of six amino acid residues. Published research identifies its sequence as His-D-Trp-Ala-Trp-D-Phe-Lys-NH₂.
GHRP-6 belongs to the growth hormone-releasing peptide class of synthetic compounds. It was developed as a small peptide for experimental study of growth hormone-releasing activity.
Research Overview Table
Chemical and Molecular Characteristics
GHRP-6 is a synthetic hexapeptide composed of six amino acid residues. Its structure contains D-tryptophan at position 2 and D-phenylalanine at position 5, with lysinamide at the C-terminus. The sequence is represented as His-D-Trp-Ala-Trp-D-Phe-Lys-NH₂. These features distinguish GHRP-6 from peptides composed entirely of standard L-amino acid residues.
The molecular formula of GHRP-6 is C₄₆H₅₆N₁₂O₆, with a molecular weight of approximately 873.0 g/mol. reports an XLogP3-AA value of 1.9, 11 hydrogen-bond donors, 9 hydrogen-bond acceptors and a topological polar surface area of 301 Ų. These physicochemical characteristics are relevant to the chemical characterization of this peptide and its distinction from other research compounds.
Certificates:
Mechanism of Action Under Investigation
GHRP-6 is investigated as an agonist of the growth hormone secretagogue receptor (GHSR), a G protein-coupled receptor. Studies in pituitary cells associate GHRP-6 receptor activation with phospholipase C signaling and phosphatidylinositol turnover. This signaling generates inositol trisphosphate (IP₃) and diacylglycerol (DAG) which are associated with intracellular calcium mobilization and protein kinase C (PKC) activation.
Studies in rat somatotrophs found that GHRP-6 produces a biphasic increase in intracellular calcium. The initial phase involves release of calcium from intracellular stores, while the later phase involves calcium entry through voltage-sensitive calcium channels and is influenced by PKC activity. These findings support calcium signaling as an important component of the investigated GHRP-6 response.
Researchers have examined these processes using phosphatidylinositol turnover assays, calcium-sensitive fluorescent probes, whole-cell patch-clamp electrophysiology, and PKC-related assays. More recent cell studies have also examined CREB phosphorylation and PKC-dependent signaling.
The complete intracellular mechanism remains unresolved. Studies support roles for calcium and protein kinase C although other signaling components may also contribute to the response.
Scientific Research Context
GHRP-6 appears in the scientific literature as a synthetic peptide used to investigate growth hormone regulation and secretagogue activity. Published research includes studies using pituitary cell systems, animal models and human endocrine studies. Much of the available evidence comes from in vitro and preclinical animal research, with a smaller body of human experimental data.
GHRP-6 Biology and Biological Pathways
Primary Biological Function
The growth hormone secretagogue receptor (GHSR) is a G protein-coupled receptor involved in endocrine regulation of growth hormone secretion. It is expressed in pituitary somatotrophs and has also been identified in other tissues. Research on GHSR biology focuses on how receptor signaling participates in the regulation of pituitary endocrine activity.
Relevant Metabolic or Signaling Pathways
GHRP-6 research has identified the phosphatidylinositol signaling pathway as a key intracellular pathway in pituitary cells. Studies report increased phosphatidylinositol turnover and formation of inositol phosphates following GHRP-6 exposure. This pathway is associated with diacylglycerol, intracellular Ca²⁺ mobilization, and protein kinase C activity. Experimental work also shows that calcium enters through voltage-dependent calcium channels.
Tissue-Specific Biology
GHSR has been studied most directly in pituitary tissue, particularly somatotroph cells involved in growth hormone secretion. Research has also examined GHSR-related responses in other human pituitary cell types. In cultured human pituitary adenoma cells, GHRP-6 produced intracellular calcium responses in GH-, TSH-, and prolactin-secreting cell preparations, while ACTH-secreting cells showed no response in that study.
Experimental Biomarkers
Researchers have measured intracellular Ca²⁺, phosphatidylinositol turnover, inositol phosphate production, and protein kinase C activity in studies of GHRP-6 signaling. Growth hormone secretion has been measured as a secretory endpoint. Studies have additionally examined GHSR expression and Pit-1 expression in pituitary cells.
Laboratory Investigation Methods
GHRP-6 has been investigated using cultured pituitary cells, calcium-sensitive fluorescent indicators, whole-cell patch-clamp recording, phosphatidylinositol turnover assays, and measurements of protein kinase C activity. These methods have been used to examine cellular responses associated with GHRP-6. Other studies have used RT-PCR, Northern blotting, Western blotting, and luciferase reporter assays to examine GHRP-6-associated changes in receptor or gene expression.
Experimental Models Used in Published Research
Published GHRP-6 research has used cell-based systems, isolated hypothalamic preparations and rat models. These approaches provide different experimental settings for examining the compound in isolated tissues or within an intact organism. The main limitations arise from removing cells or tissues from their normal physiological environment, using tumor-derived human cells, and relying on animal models that may not fully represent human biology.
Cultured Rat Pituitary Cells
Researchers have used cultured rat anterior pituitary cells as an isolated cellular model for GHRP-6. This preparation allows pituitary cells to be studied under controlled laboratory conditions. Its main limitation is that cultured cells are separated from the normal hypothalamic, vascular, and systemic environment found in an intact organism.
Dispersed Rat Anterior Pituitary Cells
Dispersed anterior pituitary cells allow individual pituitary cell populations to be examined separately. Researchers have used reverse hemolytic plaque assays to identify and quantify responding cells. Cell dispersion provides single-cell information but removes the organization and cell-to-cell interactions of intact pituitary tissue.
Human Pituitary Adenoma Cells
Researchers have used cultured cells obtained from human pituitary adenomas as a human derived experimental model. The study included cells from several adenoma types. This approach provides human cellular material, but adenoma-derived cells are tumor tissue and therefore may not fully represent normal human pituitary cells.
Rat In Vivo Models
Intact and conscious rats have been used as in vivo models in GHRP-6 studies. Specialized models have also included hypothalamus-ablated rats and hypophysectomized rats with transplanted pituitaries. These models allow it to be studied under intact or experimentally altered endocrine conditions. Limitations include species differences and physiological changes caused by surgical manipulation.
Hypothalamic Tissue Preparations
Acute rat hypothalamic explants have been used as an isolated tissue model in GHRP-6 research. Researchers can study hypothalamic secretory responses without the influence of the intact circulation. However, removing the hypothalamus from the animal eliminates normal connections with the pituitary and other physiological systems.
GHRP-6 Published Research
Growth Hormone Secretion
GHRP-6 research has focused primarily on growth hormone (GH) secretion. Human studies have examined the GH response to GHRP-6 under different physiological conditions, including differences in age, sex, obesity, fasting, and metabolic disease. Studies have also compared GHRP-6 with GHRH and examined their combined effects on GH secretion.
GHRP-6 and GHRH
Published research has investigated the relationship between GHRP-6 and growth hormone-releasing hormone (GHRH). Studies have examined whether endogenous GHRH contributes to the GH response to GHRP-6 and whether GHRP-6 and GHRH produce a greater response when given together. Human research found that blocking GHRH markedly reduced the GH response to GHRP-6, while combined GHRP-6 and GHRH produced a greater GH response than either peptide alone.
Pituitary Cellular Research
Published studies have investigated it in pituitary cells, focusing on GH secretion and intracellular signaling responses. Research has examined phosphatidylinositol turnover, inositol phosphate production, protein kinase C activity, and intracellular Ca²⁺ responses. Studies using human pituitary adenoma cells have also examined whether GHRP-6 responses vary among different pituitary cell types.
Hypothalamic and Neuroendocrine Research
Researchers have investigated whether hypothalamic regulation contributes to the endocrine response to GHRP-6. Studies have examined GHRP-6 responses in subjects with hypothalamopituitary disconnection and have also investigated interactions with somatostatinergic and cholinergic regulation. The findings indicate that the relative contributions of hypothalamic and pituitary processes have been an important subject of investigation.
Metabolic and Endocrine Conditions
GHRP-6 has also been investigated under altered metabolic and endocrine conditions. Human studies have examined responses in obesity, fasting, type 2 diabetes, and Cushing syndrome. Researchers have compared GH responses under these conditions to explore whether metabolic or endocrine disturbances alter responses to GHRP-6, GHRH or their combination.
Limitations of Current Research
Evidence Is Predominantly Preclinical
GHRP-6 research includes both animal and human studies, so the evidence base is not exclusively preclinical. However, much of the literature comes from laboratory and animal research. Findings from these systems do not fully capture the complexity of human endocrine physiology.
Human Clinical Evidence
Human studies of GHRP-6 have mostly been small and short-term. This limits how well the findings apply to larger and more diverse populations. The available studies also provide limited information about longer-term responses.
Species Differences
Species differences limit how directly animal findings can be applied to humans. Studies have reported differences in GHRP-6 responses between rats and humans, including differences in GH secretion patterns. Rat studies have also shown sex-dependent responses that were not observed in human studies, further limiting direct translation across species.
Study Design Limitations
Differences in dose, route of administration, timing and study protocol make results across GHRP-6 studies harder to compare. Studies have used different dosing levels and sampling periods, and some have examined single exposures while others have used repeated administration. These differences limit direct comparison across published findings.
Independent Replication
Multiple research groups have studied GHRP-6 particularly in relation to GH secretion and GHRH. However, the findings are not completely consistent across studies. Differences in study conditions and experimental protocols make it difficult to determine how reliably individual findings can be reproduced.
Long-Term Evidence
Long-term evidence for GHRP-6 remains limited. Human studies have mainly examined acute or short-duration exposure including a 34-hour infusion and four days of oral pretreatment. These studies do not establish how these responses may change with prolonged exposure over weeks or months.
Analytical Documentation
High-Performance Liquid Chromatography separates GHRP-6 from other compounds and helps measure peptide purity. Researchers have used HPLC to analyze and quantify GHRP-6 in laboratory studies.
LC-MS provides additional information about molecular identity and can help characterize degradation products. Studies have used RP-HPLC with ESI-MS/MS to identify chemically modified GHRP-6 species.
NMR can be used for structural and degradation studies when appropriate, although it is not required for routine identity testing.
A Certificate of Analysis records batch-specific analytical results, such as identity and purity. Analytical documentation helps confirm that laboratory material matches its stated chemical identity and quality specifications. It verifies product identity and quality, not biological performance.
Storage and Laboratory Handling
Store GHRP-6 according to the storage conditions listed on the product documentation. The supplied Certificate of Analysis specifies 2–8°C. Keep the material protected from moisture, heat and direct light, and keep the container closed when not in use.
Use GHRP-6 in a clean laboratory setting to help prevent contamination. Qualified laboratory personnel should follow established handling procedures and the instructions provided with the material. GHRP-6 is intended for laboratory research use only.
Frequently asked questions
Why choose us?
Direct SARMs is an established supplier of research peptides. We are committed to product quality, reliable service, and helpful customer support.
Our European-made products undergo rigorous purity testing, with clear product information provided for each research material. We also aim to provide dependable shipping and a smooth ordering experience.
Our support team is available to assist with orders, shipping, payments, and general questions. At Direct SARMs, we aim to make the research supply process simple, clear, and reliable.